Pharma Journalist -

Nanobiotix SA Announces that the U.S. Food and Drug Administration (FDA) has approved its Investigational New Drug (IND) Application for NBTXR3, a first-in-class nanoparticle designed…
Read More...

Confo Therapeutics announced that it has entered into a research collaboration and license agreement with Roche for the discovery, development and commercialisation of novel, small…
Read More...

DiCE Molecules announced a multi-year collaboration to discover new small molecules against multiple targets of interest to Genentech. The collaboration will build upon DiCE’s unique…
Read More...

Avista Pharma Solutions has completed extensive facility upgrades at its Longmont, Colorado site, expanding its drug product manufacturing footprint by approximately 20,000 square feet…
Read More...

BioLife Solutions announced that it has executed an agreement to supply its CryoStor cell freeze media and HypoThermosol cell storage and shipping media to Iovance Biotherapeutics.…
Read More...

Aratana Therapeutics, Inc. has received top-line pivotal field effectiveness study results for AT-016, an investigational adipose-derived allogeneic stem cell therapeutic candidate for…
Read More...

Teva Pharmaceutical Industries Ltd., announced the exclusive launch of generic Viread®1 (tenofovir disoproxil fumarate) tablets 300 mg in the U.S. Tenofovir disoproxil fumarate…
Read More...

Celltrion, Inc. announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) issued a positive opinion recommending that Herzuma®…
Read More...

PixarBio Corporation developers of NeuroRelease NR14, a 14-day post-surgical pain treatment, announces an agreement between Particle Sciences (PSI), a Lubrizol Corporation Company, to…
Read More...

Regeneron Pharmaceuticals and ISA Pharmaceuticals announced a clinical collaboration to advance ISA101, an immunotherapy targeting human papillomavirus type 16 (HPV16)-induced cancer,…
Read More...